idarubicin has been researched along with Leukemia P388 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciesielska, E; Robak, T; Szmigielska-Kaplon, A; Szmigiero, L | 1 |
| Alexander, J; Khanna, I; Lednicer, D; Mitscher, LA; Veysoglu, T; Wielogorski, Z; Wolgemuth, RL | 1 |
| Dawson, KM | 1 |
| Casazza, AM; Di Marco, A; Giuliani, F; Pratesi, G | 1 |
| Di Simone, D; Grassi, B; Malvaldi, G; Mattii, L; Petrini, M; Testi, R; Zaccaro, L | 1 |
| Bigioni, M; Capranico, G; De Isabella, P; Tinelli, S; Zunino, F | 1 |
| Kiyota, T; Kuriyama, H; Watanabe, A | 1 |
| Egawa, Y; Miyamoto, K; Sadzuka, Y; Sawanishi, H; Sonobe, T; Sugiyama, T | 1 |
| Sadzuka, Y; Sonobe, T; Sugiyama, T | 1 |
| Adams, N; Blake, C; Broadhurst, MJ; Bushnell, DJ; Hartmann, HR; Hassall, CH; Keech, E; Stratton, AR; Thomas, GJ | 1 |
| Capranico, G; Tinelli, S; Zunino, F | 1 |
| Capranico, G; Dasdia, T; Riva, A; Tinelli, S; Zunino, F | 1 |
| Kimura, Y; Matsumoto, T; Ohsaki, M; Suzuki, M; Terashima, S | 1 |
| Kimura, Y; Matsumoto, T; Suzuki, M; Terashima, S | 1 |
14 other study(ies) available for idarubicin and Leukemia P388
| Article | Year |
|---|---|
Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cladribine; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone; Survival Analysis; Time Factors; Tumor Cells, Cultured | 2002 |
Total chemical synthesis and antitumor evaluation of 4-demethoxy-10,10-dimethyldaunomycin.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Idarubicin; Indicators and Reagents; Leukemia P388; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Mice, Inbred DBA | 1984 |
Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental | 1983 |
Antileukemic activity of 4-demethoxydaunorubicin in mice.
Topics: Administration, Oral; Animals; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Idarubicin; Injections, Intravenous; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice | 1980 |
Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines.
Topics: Animals; Biological Transport; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Idarubicin; In Vitro Techniques; Leukemia P388; Mice; Mitoxantrone; Tumor Cells, Cultured; Verapamil | 1995 |
Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
Topics: Amsacrine; Animals; Base Sequence; Binding Sites; DNA; DNA Topoisomerases, Type II; DNA, Viral; Electrophoresis, Agar Gel; Idarubicin; Leukemia P388; Mice; Mitoxantrone; Molecular Sequence Data; Mutagenesis; Oligodeoxyribonucleotides; Simian virus 40; Substrate Specificity; Teniposide; Tumor Cells, Cultured | 1993 |
[Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Screening Assays, Antitumor; Female; Idarubicin; Leukemia P388; Mice; Neoplasm Transplantation; Tumor Cells, Cultured | 1996 |
Effects of 1-methyl-3-propyl-7-butylxanthine (MPBX) on idarubicin-induced antitumor activity and bone marrow suppression.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport; Bone Marrow; Bone Marrow Cells; Cell Count; Cell Division; Cell Membrane; Drug Interactions; Idarubicin; Leukemia P388; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Tissue Distribution; Xanthines | 2000 |
Improvement of idarubicin induced antitumor activity and bone marrow suppression by theanine, a component of tea.
Topics: Animals; Antibiotics, Antineoplastic; Bone Marrow; Bone Marrow Cells; Dose-Response Relationship, Drug; Drug Synergism; Glutamates; Idarubicin; Leukemia P388; Male; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Tea; Tumor Cells, Cultured | 2000 |
Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Doxorubicin; Female; Idarubicin; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1990 |
Formation, resealing and persistence of DNA breaks produced by 4-demethoxydaunorubicin in P388 leukemia cells.
Topics: Animals; Cell Survival; DNA; DNA Damage; Drug Resistance; Idarubicin; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1989 |
Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cell Nucleus; Daunorubicin; DNA; Doxorubicin; Idarubicin; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Nucleic Acid Conformation | 1987 |
Synthesis of novel 13-methyl-13-dihydroanthracyclines.
Topics: Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Daunorubicin; Idarubicin; Leukemia P388; Mice | 1986 |
Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Idarubicin; Leukemia P388; Mice | 1985 |